Container closure integrity (CCI) ensures sterility and preserves the headspace gas of parenteral drug products. More than six product recalls have been issued over the past four years due to lack of sterility assurance and CCI failures from loose vial seals. Despite rigorous process development and validation, CCI related product recalls are still common, directly resulting from reactive, rather than proactive, control strategies.